Synthetic Biology & Genetic Engineering

1910 · 116 years ago

Stéphane Leduc published the first identifiable use of the term 'synthetic biology'

Leduc used the phrase in Théorie physico-chimique de la vie et générations spontanées, and again in La Biologie Synthétique in 1912. This gave the field its eventual name decades before the molecular tools to realise it existed.

1944 · 82 years ago

Oswald Avery showed that DNA is the material of genes and chromosomes

The Canadian-American scientist's demonstration established DNA as the hereditary molecule. It became the bedrock on which all subsequent genetic research, and later synthetic biology, was built.

1953 · 73 years ago

Francis Crick and James Watson published the structure of DNA in Nature

The double-helix structure revealed how genetic information is encoded and copied. It made rational manipulation of genetic sequence conceivable.

1961 · 65 years ago

François Jacob and Jacques Monod described the operon model of gene regulation

Their study of the lac operon in E. coli established that bacteria switch genes on and off in response to their environment through molecular circuitry, giving biology its first account of genetic regulatory logic. They explicitly envisioned assembling new systems from molecular components, anticipating the engineering logic later synthetic circuits such as the repressilator were built to exploit.

1973 · 53 years ago

Cohen, Boyer et al. published the first molecular cloning and amplification of DNA in a plasmid

The P.N.A.S. paper demonstrated that DNA could be recombined and propagated in a host organism. It is widely regarded as the dawn of synthetic biology.

1976 · 50 years ago

Har Gobind Khorana's laboratory chemically synthesised the first artificial gene shown to function inside a living cell

The Indian-born biochemist's team built a yeast transfer RNA gene from individual chemical building blocks and showed it worked once inserted into bacteria, establishing that genes could be constructed rather than only extracted from existing organisms.

1978 · 48 years ago

Arber, Nathans and Smith won the Nobel Prize for the discovery of restriction enzymes

Restriction nucleases permitted easy construction of recombinant DNA molecules and analysis of individual genes. Szybalski's editorial in Gene marked the arrival of a 'new era of synthetic biology' in which new gene arrangements could be constructed and evaluated.

1988 · 38 years ago

Mullis et al. published PCR using a thermostable DNA polymerase

The Science paper removed the need to add fresh polymerase after each cycle of the polymerase chain reaction. This greatly simplified DNA mutagenesis and assembly, making routine construction of designed sequences practical.

1991 · 35 years ago

James Bailey defined metabolic engineering as a distinct discipline

His paper set out the deliberate redesign of an organism's metabolic pathways using recombinant DNA methods as a systematic engineering discipline rather than ad hoc genetic modification, a framing that underpins the industrial strain design synthetic biology later built on.

2000 · 26 years ago

Michael Elowitz and Stanislas Leibler, and separately Timothy Gardner, Charles Cantor and James Collins built the first synthetic genetic circuits

The repressilator and the genetic toggle switch wired existing genes into bacteria to oscillate or flip between states like simple electronic circuits, demonstrating that genetic regulation could be engineered predictably and marking most historians' starting point for synthetic biology as a field.

2000 · 26 years ago

Researchers synthesised the 9.6 kbp Hepatitis C virus genome from chemical oligonucleotides

The genome was assembled from chemically synthesised 60 to 80-mers. It was an early demonstration that whole viral genomes could be built from scratch.

2002 · 24 years ago

Stony Brook University researchers synthesised the 7741 bp poliovirus genome from its published sequence

The two-year effort produced the second synthetic genome, built purely from sequence data. It sharpened both the technical ambition and the biosecurity anxieties of the field.

2003 · 23 years ago

David Baker's laboratory designed Top7, a protein with a structure not found in nature

Using computational modelling rather than modifying an existing natural protein, the team designed an entirely new protein fold from scratch and had it made and shown to fold as predicted, a foundational result for the later field of de novo protein design.

2003 · 23 years ago

Researchers assembled the bacteriophage Phi X 174 genome in about two weeks

The 5386 bp genome was built far faster than the poliovirus effort. The speed increase signalled that genome synthesis was becoming a routine engineering operation.

2003 · 23 years ago

Tom Knight invented the BioBrick standardised DNA parts

BioBrick plasmids became the most widely used standardised DNA parts, enabling modular assembly of genetic constructs. They became central to the iGEM competition founded at MIT the following year.

2003 · 23 years ago

Researchers engineered an artemisinin precursor pathway in E. coli

The work showed that a multi-step natural product pathway could be transplanted into a microbial chassis. It became the flagship demonstration of synthetic biology for pharmaceutical manufacture.

2004 · 22 years ago

The iGEM competition became an independent contest built around standardised BioBrick biological parts

Growing out of an MIT course, the annual competition let student teams worldwide assemble interchangeable genetic parts into working biological systems, spreading engineering-style design principles and training a generation of synthetic biologists internationally.

2004 · 22 years ago

MIT hosted Synthetic Biology 1.0, the first international conference for the field

SB1.0 gathered the emerging community and gave synthetic biology a formal disciplinary identity. The iGEM competition was founded at MIT in the same period.

2005 · 21 years ago

Researchers built a light-sensing circuit and multicellular pattern-forming circuits in E. coli

One group developed bacterial light sensing while another designed circuits capable of multicellular pattern formation. These showed that engineered genetic circuits could process environmental inputs and coordinate across cells.

2006 · 20 years ago

Jay Keasling's laboratory engineered yeast to produce a precursor of the antimalarial drug artemisinin

Inserting genes from wormwood plants and other organisms into brewer's yeast let microbes manufacture artemisinic acid through fermentation, a process Sanofi later scaled to commercial production, becoming synthetic biology's most cited real-world humanitarian success story.

2006 · 20 years ago

Researchers engineered a synthetic circuit promoting bacterial invasion of tumour cells

The circuit directed engineered bacteria towards cancer cells. It was an early proof of concept for therapeutic applications of designed genetic systems.

2007 · 19 years ago

Commercial gene synthesis providers offered synthesis of sequences up to 2000 bp at about $1 per base pair

Several companies were reported to be selling made-to-order genetic sequences with turnaround times under two weeks. Commercial availability of cheap DNA synthesis removed a key bottleneck for designers.

2007 · 19 years ago

Researchers demonstrated a universal logic evaluator operating in mammalian cells

The work extended engineered genetic computation from bacteria to human cells. It later underpinned therapeutic biological computation.

2007 · 19 years ago

Leading DNA-synthesis companies published a plan for an oversight framework for the DNA-synthesis industry

A group led by scientists from the major synthesis firms proposed practical self-governance for screening orders. A separate paper the same year identified key issues in safety, security, ethics and the science-society interface.

2009 · 17 years ago

National Academies' Committee of Science, Technology & Law convened a symposium on challenges in the emerging field of synthetic biology

The July 2009 symposium addressed opportunities and challenges facing the discipline in the United States. It was part of an emerging governance conversation around the field.

October 2009 · 17 years ago

COSY and SYNBIOSAFE released the SYNBIOSAFE documentary on synthetic biology's societal implications

The 38-minute film was made to communicate the field and its ramifications to a broader public. It formed part of European efforts to build public dialogue around the technology.

2010 · 16 years ago

Craig Venter's team created the first cell controlled entirely by a chemically synthesised genome

Researchers synthesised the genome of Mycoplasma mycoides, JCVI-syn1.0, from digital DNA sequence data, assembling chemically synthesised fragments by yeast recombination and transplanting the result into a genomically emptied cell of a related species, which then began replicating under the synthetic genome's control. Widely described as creating the first synthetic life, it was the field's landmark demonstration that an entire functioning genome could be built to design.

• US President Barack Obama asked a bioethics commission to review the implications within days of the announcement

December 2010 · 16 years ago

US Presidential Commission for the Study of Bioethical Issues issued the report New Directions: The Ethics of Synthetic Biology

The commission judged Venter's synthetic genome a significant technical advance but not the creation of life. The report shaped the American regulatory and ethical framing of the field.

2011 · 15 years ago

Researchers engineered functional synthetic chromosome arms in yeast

The work extended genome synthesis from bacteria into a eukaryotic organism. It laid groundwork for the wider synthetic yeast genome effort.

Early 2026 · 6 months ago

Singapore expanded state-backed biofoundry capacity for synthetic biology research

Continued investment through national research agencies supported automated strain-engineering facilities intended to help local biotech firms design and test engineered organisms faster, part of a wider push to establish Singapore as a synthetic biology hub for the region.

2025 · last year

The WHO continued promoting adoption of its dual-use research governance framework

Guidance issued to help national authorities and research institutions assess and manage the risks of life sciences research that could be misused gained further uptake, though implementation remained uneven across countries with limited biosafety regulatory capacity.

2025 · last year

The Shenzhen Institute of Synthetic Biology expanded automated strain-engineering capacity

The Chinese Academy of Sciences facility, one of the largest of its kind, scaled up robotic design-build-test infrastructure intended to speed the engineering of microorganisms for industrial and agricultural applications, part of China's broader push into engineering biology.

2025 · last year

The International Biosecurity and Biosafety Initiative for Science expanded adoption of its free DNA synthesis screening tool

The Common Mechanism, designed to check gene synthesis orders against sequences of concern, gained further gene synthesis providers as users, including some in lower-income countries that had lacked access to commercial biosecurity screening software.

• A significant share of global gene synthesis capacity still operated without independent screening

2025 · last year

The UK funded new biofoundry infrastructure under its engineering biology strategy

Grants to university-based automated design-build-test facilities aimed to translate the country's strength in synthetic biology research into commercial products faster, part of a strategy naming engineering biology one of a handful of technologies judged critical to future growth.

October 2024 · 2 years ago

David Baker won the Nobel Prize in Chemistry for computational protein design

Baker's laboratory's tools for designing entirely new proteins not found in nature, recognised alongside related structure-prediction work by Demis Hassabis and John Jumper, marked synthetic biology's shift from redesigning existing organisms toward designing biological parts from scratch.

• RFdiffusion became a widely used open-source design tool after the award

May 2024 · 2 years ago

The AI Seoul Summit named biological weapons design among the frontier risks of advanced AI models

Governments and AI companies meeting in South Korea agreed voluntary commitments to test frontier models for the potential to assist in designing dangerous pathogens, extending AI safety governance into the overlap between generative design tools and biosecurity.

2024 · 2 years ago

Fzata, Inc. planned the first in-human trial of engineered live yeast therapy

The trial targets Clostridioides difficile infection using an engineered living organism as the therapeutic. It marks the entry of engineered live biotherapeutics into human clinical testing.

2024 · 2 years ago

Brazil expanded public funding for synthetic biology research

Grants from state research foundations supported university laboratories working on engineered microorganisms for agricultural and industrial applications, part of a broader Latin American effort to build synthetic biology capacity beyond the traditional US, European and Chinese centres.

2024 · 2 years ago

The Global Biofoundries Alliance added new member facilities across several continents

The network, which links automated biological engineering facilities to share standards and best practice, continued to grow beyond its original membership of wealthy-country institutions, reflecting the spread of biofoundry infrastructure to a wider set of countries.

• Most member facilities remained concentrated in the US, Europe and China

2024 · 2 years ago

The Sc2.0 consortium advanced completion of the first fully synthetic eukaryotic genome

Researchers led in part by Tianjin University worked toward finishing and consolidating a redesigned yeast genome built chromosome by chromosome, a project spanning US, UK, Chinese, Singaporean and Australian laboratories and a proof of concept for engineering complex organisms.

2023 · 3 years ago

RNA therapeutics researchers advanced RNA circuits, vaccines and genetic modifications

RNA-based systems act faster than DNA counterparts as they need no transcription, and are safer because they do not integrate into the host genome. These advances expanded applications in gene therapy, personalised medicine and vaccine development.

2023 · 3 years ago

Researchers created the first synthetic human embryos from stem cells

The embryo models were derived entirely from stem cells rather than fertilisation. The achievement raised acute ethical questions alongside its scientific significance.

2022 · 4 years ago

Clinicians reported the first successful trial of a 3D bioprinted transplant from a patient's own cells

An external ear was bioprinted to treat microtia. It was the first clinical success for patient-derived bioprinted tissue.

2020 · 6 years ago

Demis Hassabis and John M. Jumper presented AlphaFold2, predicting the structure of nearly all known proteins

The AI model enabled prediction of structures for virtually all 200 million identified proteins and has since been used by more than two million people across 190 countries. Applications include understanding antibiotic resistance and designing plastic-degrading enzymes.

2020 · 6 years ago

Scientists created the first xenobot, an AI-designed programmable organism

The xenobot was assembled from frog cells with its body plan designed by artificial intelligence. In 2021 xenobots were reported to self-replicate by gathering loose cells to form new ones.

May 2019 · 7 years ago

Researchers created a viable E. coli variant with a compressed 59-codon genome

The team reduced the natural 64 codons to 59 while still encoding 20 amino acids. It was a milestone in recoding whole genomes and producing organisms with genetics unlike anything in nature.

2019 · 7 years ago

Researchers implemented a perceptron in biological systems

The work brought machine learning primitives into engineered living systems. It opened a route to adaptive rather than fixed genetic circuits.

2019 · 7 years ago

ETH Zurich scientists created Caulobacter ethensis-2.0, the first computer-designed bacterial genome

The genome was generated entirely by computer, though no viable organism carrying it yet existed. It demonstrated that genome design could be fully computational.

2017 · 9 years ago

Build-a-Cell collaboration launched an international open-source effort to construct synthetic living cells

The large-scale collaboration was followed by national synthetic cell organisations including FabriCell, MaxSynBio and BaSyC. European efforts were unified in 2019 as the SynCellEU initiative.

2017 · 9 years ago

Researchers demonstrated the BLADE system for digital computation in human cells

Boolean logic and arithmetic through DNA excision enabled complex engineered computation inside human cells. It advanced the prospect of programmable cell therapies.

2016 · 10 years ago

The synthetic biology industry reached over 350 companies across 40 countries worth an estimated $3.9 billion

The sector had spread well beyond its founding academic centres into a global commercial market. It marked the field's transition from laboratory science to industry.

2016 · 10 years ago

Researchers automated digital circuit design in bacterial cells using computer engineering principles

The demonstration showed that genetic circuits could be compiled from specifications rather than hand-built. It moved synthetic biology closer to true engineering abstraction.

2016 · 10 years ago

The J. Craig Venter Institute created a bacterial cell with the fewest genes needed for independent life

JCVI-syn3.0, built by systematically removing genes from a synthetic genome until only around 470 remained essential, offered a minimal biological chassis for engineers to build new functions onto without unnecessary genetic complexity.

May 2014 · 12 years ago

Researchers introduced two new artificial nucleotides into bacterial DNA

The team produced the first living organism with an artificially expanded DNA code, using E. coli whose genome was replaced with an expanded-alphabet chromosome. It broke the four-letter constraint of natural genetics.

March 2012 · 14 years ago

Over 100 environmental and civil society groups issued The Principles for the Oversight of Synthetic Biology

Friends of the Earth, the International Center for Technology Assessment and the ETC Group were among the signatories. The manifesto represented organised civil-society pressure for precautionary regulation of the field.

2012 · 14 years ago

Charpentier and Doudna labs published the programming of CRISPR-Cas9 for targeted DNA cleavage

The Science paper repurposed a bacterial immune system into a programmable editing tool. It greatly simplified and expanded eukaryotic gene editing, transforming what synthetic biologists could attempt.

2012 · 14 years ago

DARPA launched its Living Foundries programme

The US defence research agency funded development of automated tools for designing, building and testing engineered organisms faster and more cheaply, helping establish the biofoundry model that later spread to universities and companies worldwide.

2011 · 15 years ago

Researchers demonstrated biological digital computation to detect and kill cancer cells

Building on the mammalian logic evaluator, the team produced a proof-of-concept therapy using engineered cellular computation. It linked synthetic circuits directly to clinical ambitions.